Document ID: chunk:federal_register_of_legislation:F2021L01907:reg:9:p2
Version: federal_register_of_legislation:F2021L01907
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 7191–8870

Hashimoto thyroiditis;
Note: Specified List 2 of drugs is defined in the Schedule 1 - Dictionary.
(13)      undergoing a course of therapeutic radiation for cancer, where the thyroid gland was in the field of radiation, within the 10 years before the clinical worsening of Hashimoto thyroiditis;
(14)      having received iodine-131 (radioactive iodine) treatment within the 10 years before the clinical worsening of Hashimoto thyroiditis;
(15)      having infection with hepatitis C virus at the time of the clinical worsening of Hashimoto thyroiditis;
(16)      being obese for at least 5 years before the clinical worsening of Hashimoto thyroiditis;
Note: being obese is defined in the Schedule 1 - Dictionary.
(17)      in a person with a prior history of a regular smoking habit as specified, permanently ceasing to smoke within the 5 years before the clinical worsening of Hashimoto thyroiditis;
Note: regular smoking habit as specified is defined in the Schedule 1 - Dictionary.
(18)      having postpartum thyroiditis within the 10 years before the clinical worsening of Hashimoto thyroiditis;
(19)      having posttraumatic stress disorder at the time of the clinical worsening of Hashimoto thyroiditis;
(20)      being pregnant or within the 12 months postpartum at the time of the clinical worsening of Hashimoto thyroiditis;
(21)      for myxoedema coma only, having an acute precipitating event within the 48 hours before that clinical worsening of Hashimoto thyroiditis;
            Note: acute precipitating event and myxoedema coma are defined in the Schedule 1- Dictionary.
(22)      inability to obtain appropriate clinical management for Hashimoto thyroiditis.